Browsing "1. Journal Papers" by Author : 675

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 14 of 14

This table browses all dspace content
Issue DateTitleJournal Title
2013Antibody-Secreting Cells with a Phenotype of Ki-67(low), CD138(high), CD31(high), and CD38(high) Secrete Nonspecific IgM during Primary Hepatitis A Virus InfectionJOURNAL OF IMMUNOLOGY
2022Applications of molecular barcode sequencing for the detection of low-frequency variants in circulating tumour DNA from hepatocellular carcinomaLIVER INTERNATIONAL
2010Ascitic fluid infection in patients with hepatitis B virus-related liver cirrhosis: culture-negative neutrocytic ascites versus spontaneous bacterial peritonitisJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
2016Clinical Utility of a New Automated Hepatitis C Virus Core Antigen Assay for Prediction of Treatment Response in Patients with Chronic Hepatitis C JOURNAL OF KOREAN MEDICAL SCIENCE
2016Combined use of AFP, PIVKA-II, and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
2014Maintaining remission in lamivudine-resistant patients with a virological response to adefovir add-on lamivudine after stopping lamivudine therapy.LIVER INTERNATIONAL
2012Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriersLIVER INTERNATIONAL
2012Prospective validation of FibroTest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B PLOS ONE
2011Quantitative hepatitis B surface antigen and hepatitis B e antigen titers in prediction of treatment response to entecavir.HEPATOLOGY
2014Risk assessment of clinical outcomes in Asian patients with chronic hepatitis B using enhanced liver fibrosis test.HEPATOLOGY
2012Serum cytokine levels in chronic hepatitis B patients receiving peginterferon alpha-2a therapy. HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL
2020Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection CLINICAL AND MOLECULAR HEPATOLOGY
2016Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus. MEDICINE
2017Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts the risk of HBV-related liver cancer developmentLIVER INTERNATIONAL
1

Browse

Links